River Road Asset Management LLC Increases Position in The Cooper Companies, Inc. $COO

River Road Asset Management LLC grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,582,867 shares of the medical device company’s stock after buying an additional 16,103 shares during the quarter. Cooper Companies accounts for about 1.4% of River Road Asset Management LLC’s investment portfolio, making the stock its 17th biggest position. River Road Asset Management LLC’s holdings in Cooper Companies were worth $129,732,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Capital World Investors grew its position in Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after acquiring an additional 2,159,233 shares during the last quarter. State Street Corp increased its stake in Cooper Companies by 2.4% in the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after purchasing an additional 207,195 shares during the period. Wellington Management Group LLP lifted its position in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the last quarter. Finally, Sustainable Growth Advisers LP boosted its stake in shares of Cooper Companies by 22.1% during the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after purchasing an additional 747,476 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

Shares of COO stock opened at $65.91 on Friday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The stock has a market capitalization of $12.85 billion, a price-to-earnings ratio of 55.86, a P/E/G ratio of 1.70 and a beta of 0.87. The stock has a fifty day simple moving average of $64.50 and a two-hundred day simple moving average of $74.02. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research report on Wednesday, March 4th. Wall Street Zen downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Finally, Citigroup reaffirmed a “neutral” rating and set a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and an average price target of $81.31.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.